Unmissable, registration is free coordinated by Dario Callegaro Sociedad Mexicana de Oncología, A.C. Ins Nal Cancerología Sarcoma European LatinAmerican Network (SELNET)

Interesting and necessary to have all the tools before planning a treatment. springermedizin.de/percutaneous-u… Sociedad Mexicana de Oncología, A.C. Sarcoma European LatinAmerican Network (SELNET) CTOS

info: [email protected]

Congrats Eduardo Ortiz Cruz

Address malnutrition in retroperitoneal #sarcoma is a key-point in prehabilitation programs. >70% pts deserve preop artificiale nutrition - reverted in 20% w/ ⬇️ complications and ⬇️ DGE. Good job @claudiazanframundo European Society of Surgical Oncology (ESSO) TARPSWG Istituto Tumori #ESSO41 Alessandro Gronchi @SoMe4sarcoma

🤗🤗🤗Sharing 'an overview of resistance to chemotherapy in #osteosarcoma and future perspectives' from Dr. Dorian Yarih Garcia-Ortega Dorian Y. García-Ortega MD, MSc, FACS, Dr. Sara Aileen Cabrera-Nieto, Dr. Haydee Sarai Caro-Sánchez, Dr. Marlid Cruz-Ramos
👉👉👉cdrjournal.com/article/view/4…

SELNET is pleased to invite you to participate in this pathology free meeting!

The results are interesting and show management in reference centers such as the gold standard. Congrats Jean-Yves Blay

Hey there! Did you know you can access TARPSWG free webinar series from here?
If you missed them 🤦🏻, if you were in the wrong timezone 🌍🌏🌎 go ahead🔥 #retroperitoneal #sarcomasurgery @SoMe4sarcoma European Society of Surgical Oncology (ESSO) Society of Surgical Oncology Australia and New Zealand Sarcoma Association Sarcoma European LatinAmerican Network (SELNET) tarpswg.org/webinars/

Modern surgery owes so much to Joseph Lister – a true icon!

Sign up, excellent speakers to keep you updated on retroperitoneal sarcoma 2022-2023 TARPSWG Educational Webinar Series :clt1481638.bmeurl.co/E57CC58. Sociedad Mexicana de Oncología, A.C. Ins Nal Cancerología Sarcoma European LatinAmerican Network (SELNET)

soqmexico.org Sociedad Mexicana de Oncología, A.C.

#Sarcoma #Desmoid
It is unfortunate that #Demoidfibromatosis is called 'sarcoma' of year 2022
#Desmoid does not have metastatic potential
It is a benign locally aggressive tumour
Words and names do matter, to avoid unnecessary stress to wider public
#Desmoid -Tumour of year 2022

Extraordinary opportunity to upgrade in #Desmooidfibromatosis
Sociedad Mexicana de Oncología, A.C. Ins Nal Cancerología